Dynamic changes of protein corona compositions on the surface of zinc oxide nanoparticle in cell culture media

Abstract

The potential applications of nanomaterials used in nanomedicine as ingredients in drug delivery systems and in other products continue to expand. When nanomaterials are introduced into physiological environments and driven by energetics, they readily associate proteins forming a protein corona (PC) on their surface. This PC could result in an alteration of the nanomaterial’s surface characteristics, affecting their interaction with cells due to conformational changes in adsorbed protein molecules. However, our current understanding of nanobiological interactions is still very limited. Utilizing a liquid chromatography–mass spectroscopy/mass spectroscopy technology and a Cytoscape plugin (ClueGO) approach, we examined the composition of the PC for a set of zinc oxide nanoparticles (ZnONP) from cell culture media typically and further analyzed the biological interaction of identified proteins, respectively. In total, 36 and 33 common proteins were investigated as being bound to ZnONP at 5 min and 60 min, respectively. These proteins were further analyzed with ClueGO, a Cytoscape plugin, which provided gene ontology and the biological interaction processes of identified proteins. Proteins bound to the surface of nanoparticles that may modify the structure, therefore the function of the adsorbed protein could be consequently affect the complicated biological processes.

Key words： ZnONPs; nanoparticles; protein corona; ClueGO

Acknowledgement

This research was supported by a National Research Foundation of Korea (NRF) awarded by the Korean government (NRF-2017R1A2B4012636).

References

1 Blunk T, Hochstrasser D F, Sanchez J C, Muller B W, Muller R H. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis, 1993, 14(12): 1382–1387

2 Ehrenberg M S, Friedman A E, Finkelstein J N, Oberdorster G, McGrath J L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials, 2009, 30(4): 603–610

3 Lundqvist M, Augustsson C, Lilja M, Lundkvist K, Dahlbäck B, Linse S, Cedervall T. The nanoparticle protein corona formed in human blood or human blood fractions. PLoS One, 2017, 12(4): e0175871

4 Beduneau A, Ma Z, Grotepas C B, Kabanov A, Rabinow B E, Gong N, Mosley R L, Dou H, Boska M D, Gendelman H E. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One, 2009, 4(2): e4343

5 Clift M J, Bhattacharjee S, Brown D M, Stone V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicology Letters, 2010, 198(3): 358–365

6 Khanna P, Ong C, Bay B H, Baeg G H. Nanotoxicity: An interplay of oxidative stress, inflammation and cell death. Nanomaterials (Basel, Switzerland), 2015, 5(3): 1163–1180

7 Lartigue L, Wilhelm C, Servais J, Factor C, Dencausse A, Bacri J C, Luciani N, Gazeau F. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: Impact on macrophage uptake. ACS Nano, 2012, 6(3): 2665–2678

8 Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, Nienhaus G U, Musyanovych A, Mailänder V, Landfester K, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano, 2011, 5(3): 1657–1669

9 Walkey C D, Olsen J B, Song F, Liu R, Liu R, Guo H, Olsen D W, Cohen Y, Emili A, Chan W C. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano, 2014, 8(3): 2439–2455

10 Gu Z, Yang Z, Chong Y, Ge C, Weber J K, Bell D R, Zhou R. Surface curvature relation to protein adsorption for carbon-based nanomaterials. Scientific Reports, 2015, 5(1): 10886

11 Marucco A, Gazzano E, Ghigo D, Enrico E, Fenoglio I. Fibrinogen enhances the inflammatory response of alveolar macrophages to TiO₂, SiO₂ and carbon nanomaterials. Nanotoxicology, 2016, 10(1): 1–9

12 Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, Yang Y, Zhou R, Zhao Y, Chai Z, Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(41): 16968–16973

13 Hajipour M J, Raheb J, Akhavan O, Arjmand S, Mashinchian O, Rahman M, Abdolahad M, Serpooshan V, Laurentj L, Mahmoudi M. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale, 2015, 7(19): 8978–8994

14 Salvati A, Pitek A S, Monopoli M P, Prapainop K, Bombelli F B, Hristov D R, Kelly P M, Åberg C, Mahon E, Dawson K A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nature Nanotechnology, 2013, 8(2): 137–143

15 Deng Z J, Liang M, Monteiro M, Toth I, Minchin R F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology, 2011, 6(1): 39–44

16 Saikia J, Yazdimamaghani M, Hadipour M. S P, Ghandehari H. Differential protein adsorption and cellular uptake of silica nanoparticles based on size and porosity. ACS Applied Materials & Interfaces, 2016, 8(50): 34820–34832

17 Anders C B, Eixenberger J E, Franco N A, Hermann R J, Rainey K D, Chess J J, Punnooseb A, Wingett D G. ZnO nanoparticle preparation route influences surface reactivity, dissolution and cytotoxicity. Environmental Science. Nano, 2018, 5(2): 572–588

18 Rasmussen J W, Martinez E, Louka P, Denise G, Wingett D G. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opinion on Drug Delivery, 2010, 7(9): 1063–1077

19 Scherzad A, Meyer T, Kleinsasser N, Hackenberg S. Molecular mechanisms of zinc oxide nanoparticle-induced genotoxicity short running title: Genotoxicity of ZnO NPs. Materials (Basel), 2017, 10(12): e1427

20 Singh N, Manshian B, Jenkins G J, Griffiths S M, Williams P M, Maffeis T G, Wright C J, Doak S H. Nanogenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials, 2009, 30(23-24): 3891–3914

21 Rajput V D, Minkina T M, Behal A, Sushkova S N, Mandzhieva S, Singh R, Gorovtsov A, Tsitsuashvili V S, Purvis W O, Ghazaryan K A, et al. Effects of zinc-oxide nanoparticles on soil, plants, animals and soil organisms: A review. Environmental Nanotechnology, Monitoring & Management, 2018, 9: 76–84

22 Wahab R, Siddiqui M A, Saquib Q, Dwivedi S, Ahmad J, Musarrat J, Al-Khedhairy A A, Shin H S. ZnO nanoparticles induced oxidative stress and apoptosis in HepG2 and MCF-7 cancer cells and their antibacterial activity. Colloids and Surfaces. B, Biointerfaces, 2014, 117(1): 267–276

23 Chevallet M, Gallet B, Fuchs A, Jouneau P H, Um K, Mintz E, Michaud-Soret I. Metal homeostasis disruption and mitochondrial dysfunction in hepatocytes exposed to sub-toxic doses of zinc oxide nanoparticles. Nanoscale, 2016, 8(43): 18495–18506

24 Zhang W, Zhao Y, Li F, Li L, Feng Y, Min L, Ma D, Yu S, Liu J, Zhang H, et al. Zinc oxide nanoparticle caused plasma metabolomic perturbations correlate with hepatic steatosis. Frontiers in Pharmacology, 2018, 9: 57

25 Leite-Silva V R, Liu D C, Sanchez W Y, Studier H, Mohammed Y H, Holmes A, Becker W, Grice J E, Benson H A, Roberts M S. Effect of flexing and massage on in vivo human skin penetration and toxicity of zinc oxide nanoparticles. Nanomedicine (London), 2016, 11(10): 1193–1205

26 Sayes C M, Reed K L, Warheit D B. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2007, 97(1): 163–180

27 Xia T, Zhao Y, Sager T, George S, Pokhrel S, Li N, Schoenfeld D, Meng H, Lin S, Wang X, et al. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano, 2011, 5(2): 1223–1235

28 Warheit D B, Sayes C M, Reed K L. Nanoscale and fine zinc oxide particles: Can in vitro assays accurately forecast lung hazards following inhalation exposures? Environmental Science & Technology, 2009, 43(20): 7939–7945

29 Giau V V, An S S. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer’s disease. Journal of the Neurological Sciences, 2016, 15(360): 141–152

30 Mana M N, Fougères P A, Leung Y H, Liu F, Djurišić A B, Giesy J P, Leung K M Y. Physicochemical characteristics and toxicity of surface-modified zinc oxide nanoparticles to freshwater and marine microalgae. Scientific Reports, 2017, 7(1): 15909

31 Milani S, Bombelli F B, Pitek A S, Dawson K A, Rädler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: Soft and hard corona. ACS Nano, 2012, 6(3): 2532–2541

32 Pederzoli F, Tosi G, Vandelli M A, Belletti D, Forni F, Ruozi B. Protein corona and nanoparticles: How can we investigate on? Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 2017, 9(6): e1467

33 Rao A, Long H, Harley-Trochimczyk A, Pham T, Zettl A, Carraro C, Maboudian R. In situ localized growth of ordered metal oxide hollow sphere array on microheater platform for sensitive, ultra-fast gas sensing. ACS Applied Materials & Interfaces, 2017, 9(3): 2634–2641

34 Schöttler S, Landfester K, Mailänder V. Controlling the stealth effect of nanocarriers through understanding the protein corona. Angewandte Chemie International Edition in English, 2016, 55(31): 8806–8815

35 Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature Nanotechnology, 2013, 8(10): 772–781

36 Saha K, Rahimi M, Yazdani M, Kim S T, Moyano D F, Hou S, Das R, Mout R, Rezaee F, Mahmoudi M, et al. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano, 2016, 10(4): 4421–4430

37 Shannahan J H, Brown J M, Chen R, Ke P C, Lai X, Mitra S, Witzmann F A. Comparison of nanotube-protein corona composition in cell culture media. Small, 2013, 9(12): 2171–2181

38 Shannahan J H, Lai X, Ke P C, Podila R, Brown J M, Witzmann F A. Silver nanoparticle protein corona composition in cell culture media. PLoS One, 2013, 8(9): e74001

39 Kim K M, Choi M H, Lee J K, Jeong J, Kim Y R, Kim M K, Paek S M, Oh J M. Physicochemical properties of surface charge-modified ZnO nanoparticles with different particle sizes. International Journal of Nanomedicine, 2014, 9(Suppl 2): 41–56

40 Shim K H, Hulme J, Maeng E H, Kim M K. An S S A. Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate. International Journal of Nanomedicine, 2014, 9(Suppl 2): 217–224

41 Cedervall T, Lynch I, Foy M, Berggård T, Donnelly S C, Cagney G, Linse S, Dawson K A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angewandte Chemie International Edition in English, 2007, 46(30): 5754–5756

42 Lara S, Alnasser F, Polo E, Garry D, Giudice M C L, Hristov D R, Rocks L, Salvati A, Yan Y, Dawso N K A. Identification of receptor binding to the biomolecular corona of nanoparticles. ACS Nano, 2017, 11(2): 1884–1893

43 Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bond drugs across the blood-brain barrier. Journal of Drug Targeting, 2002, 10(4): 317–325

44 Palchetti S, Colapicchioni V, Digiacomo L, Caracciolo G, Pozzi D, Capriotti A L, La Barbera G, Laganà A. The protein corona of circulating PEGylated liposomes. Biochimica et Biophysica Acta, 2016, 1858(2): 189–196

45 Ritz S, Schöttler S, Kotman N, Baier G, Musyanovych A, Kuharev J, Landfester K, Schild H, Jahn O, Tenzer S, et al. Protein corona of nanoparticles: Distinct proteins regulate the cellular uptake. Biomacromolecules, 2015, 16(4): 1311–1321

46 Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson K A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(38): 14265–14270

47 Townson J L, Lin Y S, Agola J O, Carnes E C, Leong H S, Lewis J D, Haynes C L, Brinker C J. Differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles. Journal of the American Chemical Society, 2013, 135(43): 16030–16033

48 Röcker C, Pötzl M, Zhang F, Parak W J, Nienhaus G U. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature Nanotechnology, 2009, 4(9): 577–580

49 Deng Z J, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin R F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology, 2009, 20(45): 455101

50 Lesniak A, Campbell A, Monopoli M P, Lynch I, Salvati A, Dawson K A. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials, 2010, 31(36): 9511–5918

51 Lesniak A, Fenaroli F, Monopoli M P, Åberg C, Dawson K A, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano, 2012, 6(7): 5845–5857

52 Lesniak A, Salvati A, Santos-Martinez M J, Radomski M W, Dawson K A, Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. Journal of the American Chemical Society, 2013, 135(4): 1438–1444

53 Murdock R C, Braydich-Stolle L, Schrand A M, Schlager J J, Hussain S M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicological Sciences: An Official Journal of the Society of Toxicology, 2008, 101(2): 239–253

54 Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi M A, Cingolani R, Pompa P P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano, 2010, 4(12): 7481–7491

55 Wang J, Jensen U B, Jensen G V, Shipovskov S, Balakrishnan V S, Otzen D, Pedersen J S, Besenbacher F, Sutherland D S. Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner. Nano Letters, 2011, 11(11): 4985–4991

56 Zhou Y, Fang X, Gong Y, Xiao A, Xie Y, Liu L, Cao Y. The interactions between ZnO nanoparticles (NPs) and α-linolenic acid (LNA) complexed to BSA did not influence the toxicity of ZnO NPs on HepG2 cells. Journal of the American Chemical Society, 2017, 135(4): 1438–1444

57 Go M R, Yu J, Bae S H, Kim H J, Choi S J. Effects of interactions between ZnO nanoparticles and saccharides on biological responses. International Journal of Molecular Sciences, 2018, 19(2): 486